US Stock MarketDetailed Quotes
ORGS Orgenesis
- 0.980
- -0.200-16.95%
15min DelayTrading Nov 19 10:42 ET
5.07MMarket Cap-40P/E (TTM)
1.180High0.940Low6.48KVolume1.170Open1.180Pre Close6.89KTurnover0.14%Turnover RatioLossP/E (Static)5.17MShares10.79952wk High-0.21P/B4.52MFloat Cap0.87052wk Low--Dividend TTM4.61MShs Float168.000Historical High--Div YieldTTM20.32%Amplitude0.870Historical Low1.063Avg Price1Lot Size
About Orgenesis Company
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Company Profile
SymbolORGS
Company NameOrgenesis
Listing DateMar 13, 2018
Founded2008
CEOMs. Vered Caplan
MarketPink Market
Employees146
Fiscal Year Ends12-31
Address20271 Goldenrod Lane
CityGermantown
ProvinceMaryland
CountryUnited States of America
Zip Code20876
Phone1-480-659-6404
Websitehttp://www.orgenesis.com
Company Executives
- Name
- Position
- Salary
- Vered Caplan
- Chairperson of the Board and Chief Executive Officer
- 341.38K
- Victor Miller
- Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
- --
- Mark Goodman
- Director
- --
- Kevin Choquette
- Director
- --
- Yaron Adler
- Independent Director
- 64.64K
- Dr. Itzhak Vider
- Independent Director
- --
- Ashish Nanda
- Independent Director
- 69.91K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data